<?xml version="1.0" encoding="UTF-8"?>
<bio>
 <graphic xlink:href="fx1_lrg" xmlns:xlink="http://www.w3.org/1999/xlink"/>
 <p>
  <bold>Eleonora Aricò</bold> graduated in Biological Sciences in 1998 at the University “La Sapienza” in Rome, where she also received the specialization degree in “Applied Genetics” in 2002. Since then, she works as Researcher at the Istituto Superiore di Sanità, in Rome, where she carries out her research activity in the field of cancer immunology and immunotherapy, in both animal models and clinical studies, with a particular focus on type I Interferons. She worked as visiting fellow at the University of Edinburgh, Scotland, UK, in the context of an European Grant on type I IFN as immune adjuvant (2000). She also spent two years at the Department of Transfusion Medicine of the National Institute of Health (Bethesda, US), working for a joint Italy-US program on clinical studies with IFN-I (2004–2006). In 2017, she joined FaBioCell, the cell factory of the Istituto Superiore di Sanità, where she takes part in the development and clinical application of cell-based immunotherapy strategies for cancer and regenerative diseases.
 </p>
</bio>
